SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-24-021580
Filing Date
2024-03-12
Accepted
2024-03-12 08:04:03
Documents
7

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0201516-s3_cadrenal.htm S-3 504830
2 FORM OF INDENTURE ea020151601ex4-3_cadrenal.htm EX-4.3 372810
3 OPINION OF BLANK ROME LLP ea020151601ex5-1_cadrenal.htm EX-5.1 28488
4 CONSENT OF WITHUMSMITH+BROWN, P.C., INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIR ea020151601ex23-1_cadrenal.htm EX-23.1 2125
5 CALCULATION OF FILING FEE TABLE ea020151601ex-fee_cadrenal.htm EX-FILING FEES 20424
6 GRAPHIC image_001.jpg GRAPHIC 4941
7 GRAPHIC ex5-1_001.jpg GRAPHIC 2729
  Complete submission text file 0001213900-24-021580.txt   940546
Mailing Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082
Business Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082 904-300-0701
Cadrenal Therapeutics, Inc. (Filer) CIK: 0001937993 (see all company filings)

IRS No.: 880860746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-277835 | Film No.: 24740254
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)